MedTrace Logo

Acne Vulgaris Related Microbiology and Serology

NCT04056598 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-01-06

No results posted yet for this study

Summary

This will be an investigation to determine the quality of the serological immune responses against Propionibacterium acnes (P. acnes) in acne patients compared to healthy individuals. In particular, the investigators will measure serum antibody titers against P. acnes surface antigens, and the efficiency of antibody-mediated phagocytic killing of P. acnes.

Conditions

  • Acne Vulgaris

Interventions

DIAGNOSTIC_TEST

Study of humoral immunity

Analysis: Surface antigen ELISA, recognition of living P. acnes bacteria via FACS, 16SRNA study of microbiome, SLST typing of P. acnes bacteria

Sponsors & Collaborators

  • CRAT

    collaborator UNKNOWN

  • Sanofi

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-18
Primary Completion
2019-09-30
Completion
2019-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04056598 on ClinicalTrials.gov